Kitano Hospital, Chief of Dental and Oral Surgery Masaru TakahashiDevelopment is being carried out based on many years of research by doctors.Teething medicine.

It is expected to be a drug to help patients with congenital anodontia, who are born without permanent teeth, to grow teeth. Dr. Takahashi is currently co-founder of the Kyoto University ventureTregem Biopharmais currently preparing and developing for clinical trials, and has now been able to raise funds for research and development through a third-party allotment of new shares.

Kitano Hospital, as a medical research institute, will continue to cooperate with this research in order to put it into practical use as soon as possible.

• Kyoto University startup raises 450 million yen to test teething drug safety – Nikkei
• Kyoto University-based dental drug discovery startup TreGem BioPharma raises 450 million yen to accelerate research and development of tooth regenerative medicine – TechCrunch Japan